These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25223839)
1. Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. Ozben S; Huseyinoglu N; Hanikoglu F; Guvenc TS; Yildirim BZ; Cort A; Ozdem S; Ozben T Eur J Clin Invest; 2014 Nov; 44(11):1045-52. PubMed ID: 25223839 [TBL] [Abstract][Full Text] [Related]
2. The levels of advanced oxidation protein products in patients with obstructive sleep apnea syndrome. Yağmur AR; Çetin MA; Karakurt SE; Turhan T; Dere HH Ir J Med Sci; 2020 Nov; 189(4):1403-1409. PubMed ID: 32279237 [TBL] [Abstract][Full Text] [Related]
3. [Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome]. Yang XH; Liu X; Shang J; Liu HG; Xu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):274-9. PubMed ID: 23945341 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Mancuso M; Bonanni E; LoGerfo A; Orsucci D; Maestri M; Chico L; DiCoscio E; Fabbrini M; Siciliano G; Murri L Sleep Med; 2012 Jun; 13(6):632-6. PubMed ID: 22534161 [TBL] [Abstract][Full Text] [Related]
5. Using advanced oxidation protein products and ischaemia-modified albumin to monitor oxidative stress levels in patients with drug-induced liver injury. Xiao LL; Zhang F; Zhao YL; Zhang LJ; Xie ZY; Huang KZ; Ouyang XX; Wu XX; Xu XW; Li LJ Sci Rep; 2020 Oct; 10(1):18128. PubMed ID: 33093629 [TBL] [Abstract][Full Text] [Related]
6. Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia. Witthaus MW; Nipa F; Yang JH; Li Y; Lerner LB; Azadzoi KM J Urol; 2015 May; 193(5):1692-9. PubMed ID: 25463994 [TBL] [Abstract][Full Text] [Related]
7. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome. Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986 [TBL] [Abstract][Full Text] [Related]
8. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease. Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484 [TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209 [TBL] [Abstract][Full Text] [Related]
10. Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. Bruno RM; Rossi L; Fabbrini M; Duranti E; Di Coscio E; Maestri M; Guidi P; Frenzilli G; Salvetti A; Taddei S; Bonanni E; Ghiadoni L J Hypertens; 2013 Jul; 31(7):1456-64; discussion 1464. PubMed ID: 23965549 [TBL] [Abstract][Full Text] [Related]
11. Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome. He Y; Chen R; Wang J; Pan W; Sun Y; Han F; Wang Q; Liu C Respir Med; 2016 Nov; 120():25-30. PubMed ID: 27817812 [TBL] [Abstract][Full Text] [Related]
12. Advanced oxidation protein products in obstructive sleep apnea. Sonka K; Fialová L; Volná J; Jiroutek P; Vávrová J; Kemlink D; Pretl M; Kalousová M Prague Med Rep; 2008; 109(2-3):159-65. PubMed ID: 19548597 [TBL] [Abstract][Full Text] [Related]